Strides Pharma Science is planning to raise funds through issuance of Non-Convertible Debentures (NCD) on a private placement basis. A meeting of the Committee of Directors is scheduled to be held on July 25, 2022, inter alia, to consider and approve the same.
Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.
